Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
200 pregnant women with symptomatic placenta previa with previous bleeding attacks attending
Ain Shams University maternity hospital will be recruited and randomized to receive either
tranexamic acid tablets (500mg four times daily) or placebo. Amount of bleeding during
antepartum bleeding attacks will be estimated (by hemoglobin change from baseline at
admission till delivery).